- Trials with a EudraCT protocol (78)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
78 result(s) found for: Cardiologist.
Displaying page 1 of 4.
| EudraCT Number: 2016-000473-20 | Sponsor Protocol Number: CLCZ696B3402 | Start Date*: 2016-08-18 | |||||||||||
| Sponsor Name:Novartis Pharma services AG | |||||||||||||
| Full Title: A prospective evaluation of natriuretic peptide based referral of CHF patients in primary care | |||||||||||||
| Medical condition: Chronic heart failure with reduced ejection fraction | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HR (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-000510-37 | Sponsor Protocol Number: GTN-1 290107 | Start Date*: 2008-04-25 |
| Sponsor Name:Nottingham Univeristy Hospitals NHS Trust | ||
| Full Title: The effect of transdermal GTN on arterial size and procedure outcomes in transradial coronary angiography - pilot study. | ||
| Medical condition: The trial is to investigate whether applying a transdermal GTN patch over the radial artery reduces spasm of the artery during coronary angiography. This is a pilot study | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-001393-58 | Sponsor Protocol Number: T21-118 | Start Date*: 2023-04-13 |
| Sponsor Name:Hagaziekenhuis | ||
| Full Title: POMPAE trial: Peri-Operative Magnesium infusion to Prevent Atrial fibrillation Evaluated. | ||
| Medical condition: Atrial fibrillation | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-001270-28 | Sponsor Protocol Number: Protokół_ASAPOL_wersja4_z_dnia_27_0 | Start Date*: 2012-09-21 |
| Sponsor Name:Medical Centre of Postgraduate Education, Poland | ||
| Full Title: The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Continuing or Discontinuing on Aspirin: a Multicenter, Double-blind, Placebo-controlled, Randomized Clinical Trial | ||
| Medical condition: Bleeding after removal large colorectal polyps in patients taking aspirin in profilactic doses or placebo | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: PL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-003265-38 | Sponsor Protocol Number: PTC743-NEU-005-FA | Start Date*: 2022-10-22 |
| Sponsor Name:PTC Therapeutics, Inc. | ||
| Full Title: An Open-Label Study to Evaluate Pharmacokinetics, Safety, and Efficacy of Vatiquinone in Children With Friedreich Ataxia Younger Than 7 Years of Age | ||
| Medical condition: Friedreich Ataxia | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-002170-52 | Sponsor Protocol Number: 66242 | Start Date*: 2019-03-04 |
| Sponsor Name:VU University Medical Center (VUmc) | ||
| Full Title: TrimetaziDine as a Performance-enhancING drug in Heart Failure with Preserved Ejection Fraction | ||
| Medical condition: Heart failure with preserved ejection fraction (HFpEF) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-003461-17 | Sponsor Protocol Number: 71272 | Start Date*: 2020-01-07 |
| Sponsor Name:Amsterdam UMC, location VUmc | ||
| Full Title: Pathophysiological relevance of IRON deficiency and related mitochondrial dysfunction in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF) | ||
| Medical condition: Heart failure with preserved ejection fraction | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-001285-15 | Sponsor Protocol Number: KOIIM-2019-1 | Start Date*: 2019-06-28 |
| Sponsor Name:University Medical Centre Ljubljana | ||
| Full Title: Platelet inhibition with cangrelor in comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention | ||
| Medical condition: Comatose survivors of out-of-hospital cardiac arrest undergoing primary percutaneous coronary intervention | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-004756-69 | Sponsor Protocol Number: M/100977/24 | Start Date*: 2008-10-21 |
| Sponsor Name:Laboratorios Almirall, S.A. | ||
| Full Title: A randomised, double-blind, placebo-controlled, 4-way crossover clinical trial to assess the efficacy, safety, tolerability and pharmacokinetics of single doses of LAS100977 administered by inhalat... | ||
| Medical condition: Adult male subjects, aged 18 to 70 years, clinically diagnosed of persistent asthma (according to GINA guidelines 2007 update) for at least 6 months before screening, but who are otherwise in good ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-004900-37 | Sponsor Protocol Number: DC05/RUP/I/13 | Start Date*: 2012-11-20 |
| Sponsor Name:J. Uriach y Compañía, S.A. | ||
| Full Title: A Phase I, Randomised, Double-blind, Placebo-controlled, Parallel group study to assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of oral Rupatadine in Healthy Japanese Subjec... | ||
| Medical condition: This is a Phase I study in helathy subjects. No condition is being treated. The IMP is approved for symptomatic treatment of allergic rhinitis and urticaria in adults and adolescents (over 12 yea... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-001989-15 | Sponsor Protocol Number: HomRate04_2012 | Start Date*: 2012-09-17 | |||||||||||
| Sponsor Name:Universität des Saarlandes | |||||||||||||
| Full Title: A randomised, placebo controlled, double blind, cross-over, single center clinical Study to investigate the effect of heart rate reduction with ivabradine on endothelial function and vascular stiff... | |||||||||||||
| Medical condition: Stable coronary heart disease. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-001383-10 | Sponsor Protocol Number: 57340 | Start Date*: 2016-07-04 |
| Sponsor Name:Rijnstate ziekenhuis | ||
| Full Title: Evaluating the effect of short term withdrawal of PPI's in patients for reducing stomach wall uptake with 99mTc Sestamibi for myocardial perfusion imaging | ||
| Medical condition: The goal is to acquire knowledge about the impact of the withdrawal of PPI’s, so as to minimize disturbance of the stomach wall in myocardial perfusion imaging. The associated main question is ther... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-000269-27 | Sponsor Protocol Number: DSCK101 | Start Date*: 2014-11-06 |
| Sponsor Name:German Foundation for Chronically Ill | ||
| Full Title: Efficacy and tolerance of Beta Blocker and Procoralan uptitration in chronic heart failure patients under telemedical control: „70 bpm on day 28“ | ||
| Medical condition: Patients with chronic heart failure and resting heart rate of ≥ 75 bmp | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-015638-31 | Sponsor Protocol Number: VitD-CHF | Start Date*: 2010-03-22 | |||||||||||
| Sponsor Name:University Medical Center Groningen | |||||||||||||
| Full Title: An open-label, blinded-endpoint, randomized, prospective trial investigating the effects of vitamin D administration on plasma renin activity in patients with stable chronic heart failure. | |||||||||||||
| Medical condition: Heart Failure | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-023779-24 | Sponsor Protocol Number: M10-1028 | Start Date*: 2010-12-06 |
| Sponsor Name:Stichting Toegepast Caridologisch Onderzoek | ||
| Full Title: A Comparison of Drug Eluting and Bare Metal Stents with Bivalirudin during PCI or Bivalirudin for 4 hours in Acute Coronary Syndromes. The Eindhoven Reperfusion Study | ||
| Medical condition: Patients with ACS who are scheduled for primary PCI (STEMI) or for immediate PCI < 2.5 hours or early PCI < 48 hours (NSTEMI) and who are pre-treated with HLD clopidogrel | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-002510-23 | Sponsor Protocol Number: SR062014 | Start Date*: 2014-09-17 |
| Sponsor Name:University hospitals of Leuven | ||
| Full Title: as an adjuvant to sevoflurane anaesthesia in children undergoing interventional or diagnostic cardiac catheterization: a randomized controlled clinical trial | ||
| Medical condition: Xenon anesthesia in children undergoing cardiac catheterization | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-002304-16 | Sponsor Protocol Number: 130873-2004 | Start Date*: 2005-06-14 |
| Sponsor Name:South Tees Hospitals NHS Foundation Trust | ||
| Full Title: The STARS (STeroids Against Re-Stenosis) Trial [THE USE OF Peri-PROCEDURAL ORAL CORTICOSTERIODS TO PREVENT IN-SEGMENT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION.] | ||
| Medical condition: coronary artery disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-002090-12 | Sponsor Protocol Number: Ilocard | Start Date*: 2009-03-04 | |||||||||||
| Sponsor Name:Hospital of the university of munich | |||||||||||||
| Full Title: Effect of Iloprost inhalation before and during extracorporeal circulation (ECC) on perioperative morbidity and outcome in high risk cardiac surgical patients | |||||||||||||
| Medical condition: In this study effects of the intra operative, prophylactic inhalation of Iloprost (Ventavis) before and during extracorporal circulation on perioperative morbidity and outcome in high risk cardiac ... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-004433-24 | Sponsor Protocol Number: 59498 | Start Date*: 2017-05-17 |
| Sponsor Name:Leids Universitair Medisch Centrum | ||
| Full Title: ACE inhibition in Fontan patients: its effect on body fluid regulation. | ||
| Medical condition: Patients with univentricular hearts palliated by the Fontan procedure | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2018-002623-42 | Sponsor Protocol Number: 66623 | Start Date*: 2019-02-18 | |||||||||||
| Sponsor Name:Academic Medical Center | |||||||||||||
| Full Title: Vasospastic angina treatment by Endothelin Receptor Antagonism; a proof of concept study | |||||||||||||
| Medical condition: Vasospastic angina, i.e. epicardial vasospasm or microvascular coronary dysfunction. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
